Abstract:Transient gene expression (TGE) is a rapid method for the production of recombinant proteins in mammalian cells. While the volumetric productivity of TGE has improved significantly over the past decade, most methods involve extensive cell line engineering and plasmid vector optimization in addition to long fed batch cultures lasting up to 21 days. Our colleagues have recently reported the development of a CHO K1SV GS-KO host cell line. By creating a bi-allelic glutamine synthetase knock out of the original CHOK1SV host cell line, they were able to improve the efficiency of generating high producing stable CHO lines for drug product manufacturing. We developed a TGE method using the same CHO K1SV GS-KO host cell line without any further cell line engineering. We also refrained from performing plasmid vector engineering. Our objective was to setup a TGE process to mimic protein quality attributes obtained from stable CHO cell line. Polyethyleneimine (PEI)-mediated transfections were performed at high cell density (4 × 10(6) cells/mL) followed by immediate growth arrest at 32 °C for 7 days. Optimizing DNA and PEI concentrations proved to be important. Interestingly, found the direct transfection method (where DNA and PEI were added sequentially) to be superior to the more common indirect method (where DNA and PEI are first pre-complexed). Moreover, the addition of a single feed solution and a polar solvent (N,N dimethylacetamide) significantly increased product titers. The scalability of process from 2 mL to 2 L was demonstrated using multiple proteins and multiple expression volumes. Using this simple, short, 7-day TGE process, we were able to successfully produce 54 unique proteins in a fraction of the time that would have been required to produce the respective stable CHO cell lines. The list of 54 unique proteins includes mAbs, bispecific antibodies, and Fc-fusion proteins. Antibody titers of up to 350 mg/L were achieved with the simple 7-day process. Titers were increased to 1 g/L by extending the culture to 16 days. We also present two case studies comparing product quality of material generated by transient HEK293, transient CHO K1SV GS-KO, and stable CHO K1SV KO pool. Protein from transient CHO was more representative of stable CHO protein compared to protein produced from HEK293.

Improvement strategies for transient gene expression in mammalian cells

Maximizing the Production of Recombinant Proteins in Plants: from Transcription to Protein Stability

Mammalian Cell Protein Expression for Biopharmaceutical Production

Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells

Optimization of a transient antibody expression platform towards high titer and efficiency

Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics

Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells

Transient Recombinant Protein Expression in Mammalian Cells

Advances on Highly Efficient Expression System of Mammalian Cells

Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells

Current strategies for the development of high-yield HEK293 cell lines

Improved recombinant gene expression in CHO cells using matrix attachment regions

Optimization of a novel expression system for recombinant protein production in CHO cells

A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment

Chromatin-modifying elements for recombinant protein production in mammalian cell systems

Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells

Evaluation of two transposases for improving expression of recombinant proteins in Chinese hamster ovary cell stable pools by co‐transfection and supertransfection approaches

Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems

A highly efficient transposon vector system for recombinant protein expression in CHO cells

Synthetic enhancers including TFREs improve transgene expression in CHO cells

A high-titer scalable Chinese hamster ovary transient expression platform for production of biotherapeutics